Venture1st invests corporate venture capital in start-ups during their first three to five years, in stages varying from bootstrapped to series C. As the successor of the Cline Group's marketing, business advisory, and investment arms, Venture1st builds on more than 17 years of experience. The firm is involved in overseeing product development, business strategy, marketing and PR, business connections, and financial investment. Venture1st is launching a fund geared toward companies in the United States and Israel that innovate in m-health, health IT, big data, and enterprise software.